Sellbyville, Delaware, April 24, 2018 (GLOBE NEWSWIRE) --
Global Neurovascular Devices Market is projected to surpass USD 2 billion by 2024; according to a new research report by Global Market Insights. Increasing adoption of minimally invasive surgical procedures is primary factor driving neurovascular devices market growth. Some of the advantages of minimally invasive surgeries such as smaller incision length, less discomfort, reduced blood loss during the surgery, and shorter hospitalization stay make it a preferable treatment option fuelling industry expansion.
Increasing incidences and mortality associated with neurological diseases such as brain aneurysm and ischemic strokes in the developed countries is another major impact rendering driver for neurovascular devices market growth. Stroke is the third leading cause of death and the main cause of long term disability in Western countries. This will fuel demand for neurovascular devices for treatment of such diseases.
Advancement in neurovascular technology such as stent retriever technology used for the treatment of ischemic stroke along with favorable government initiatives to develop healthcare infrastructure will accelerate market growth in the coming years.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/794
However, high cost of neurovascular devices and dearth of neurosurgeons in the developing regions will hamper market growth in the future.
Embolic coils held over 30% of overall market size in 2017 followed by neurovascular thrombectomy devices. Increasing incidences of acute ischemic stroke with large artery occlusion along with development of novel solutions by industry players will foster neurovascular thrombectomy segment growth in the coming years.
Flow diverters will witness more than 3% CAGR over the coming years due to increasing prevalence of cerebrovascular diseases along with availability of various flow diverters used for treating patients with unruptured large intracranial aneurysms.
Browse key industry insights spread across 230 pages with 263 market data tables & 10 figures & charts from the report, “Neurovascular Devices Market” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/neurovascular-devices-market
Coiling procedure dominated the market in 2017 by holding more than 35% of total market share owing to increasing demand for surgical procedures with minimum invasion catering to unmet medical needs of patients.
Stenting technique will witness over 4.5% CAGR over the forecast period due to increased adoption of carotid stents among neurosurgeons as an effective treatment option for ischemic strokes, aneurysm and stenosis. Neuroform, Solitaire, Enterprise, and Leo plus are among the popularly used stents in the market for stenting techniques to treat intracranial aneurysms.
Ischemic strokes accounted for more than 42% industry share and is expected to experience similar trend over the future years. Stenosis segment will witness considerable growth over the coming years owing to rising geriatric patients suffering from aortic stenosis that leads to surging demand for neurovascular devices.
Hospitals accounted for more than 85% of the business revenue share in 2017. Increasing usage of neurovascular devices owing to rising number of advanced minimally invasive treatments performed in these facilities will propel segment growth.
U.S. neurovascular devices market size was around USD 480 million in 2017 and anticipated to surpass USD 600 million by 2024. Increasing incidences of Hemorrhagic stroke along with high adoption of technologically advanced products in the country will augment regional revenue size.
UK neurovascular devices market is well established and present excellent opportunities in future. Increasing geriatric population coupled with increasing prevalence of ischemic stroke and neurological disorders should drive future market growth.
China neurovascular devices market will witness 6% growth from 2018 to 2024. Increasing prevalence of neurological disorders along with large proportion of undiagnosed population will foster demand for neurovascular devices. Increasing geriatric patient pool along with favourable government initiatives to improve healthcare infrastructure are driving factors for industry growth.
Some of the key industry players operating in global neurovascular devices market are Medtronic, Penumbra, Terumo Corporation, Stryker and Johnson & Johnson (Depuy Synthes). The industry players resort to innovative product launch and strategic acquisition to strengthen their market foothold.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/794
Browse Related Reports:
- Neurostimulation Devices Market Size 2017 – 2024
Neurostimulation devices Market share was valued over USD 5.4 billion in 2016 and is expected to witness more than 15.0% CAGR from 2017 to 2024. Growing prevalence of neurological disorders coupled with adoption of innovative and technologically advanced products should drive the neurostimulation devices market trends.
https://www.gminsights.com/industry-analysis/neurostimulation-devices-market-report
- CT Scanner Market Size 2017 – 2024
CT Scanner Market share was valued over USD 4.7 billion in 2016 and is expected to witness more than 5% CAGR from 2017 to 2024. Increasing prevalence of chronic diseases across the globe will serve to be a high impact rendering factor for CT scanner market growth.
https://www.gminsights.com/industry-analysis/ct-scanner-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.